Covered recipient · General Payments record
WILLIAM J FEENEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,807.51
- Reported across 271 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $547.47 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $182.25 | 12 |
| GlaxoSmithKline, LLC. | $115.20 | 1 |
| Galderma Laboratories, L.P. | $86.71 | 4 |
| PFIZER INC. | $60.26 | 3 |
| Lilly USA, LLC | $42.53 | 2 |
| Otsuka America Pharmaceutical, Inc. | $21.17 | 1 |
| Novo Nordisk AS | $20.24 | 1 |
| Astellas Pharma US Inc | $19.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.22 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717072 | CMS |
| ABBVIE INC. | $8.39 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717074 | CMS |
| ABBVIE INC. | $30.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717076 | CMS |
| ABBVIE INC. | $24.74 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717078 | CMS |
| ABBVIE INC. | $11.63 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717080 | CMS |
| ABBVIE INC. | $7.69 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717082 | CMS |
| ABBVIE INC. | $13.85 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717084 | CMS |
| ABBVIE INC. | $6.59 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717086 | CMS |
| ABBVIE INC. | $29.00 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717088 | CMS |
| ABBVIE INC. | $5.41 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717090 | CMS |
| ABBVIE INC. | $8.20 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717092 | CMS |
| ABBVIE INC. | $6.53 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103717094 | CMS |
| Astellas Pharma US Inc | $19.11 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139410757 | CMS |
| Galderma Laboratories, L.P. | $16.43 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145297029 | CMS |
| Galderma Laboratories, L.P. | $25.07 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145297031 | CMS |
| Galderma Laboratories, L.P. | $21.32 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145297033 | CMS |
| Galderma Laboratories, L.P. | $23.89 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145297035 | CMS |
| GlaxoSmithKline, LLC. | $115.20 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116361893 | CMS |
| Lilly USA, LLC | $15.70 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135454007 | CMS |
| Lilly USA, LLC | $26.83 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135515882 | CMS |
| Novo Nordisk Inc | $20.24 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096887886 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.17 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118891788 | CMS |
| PFIZER INC. | $22.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131449461 | CMS |
| PFIZER INC. | $17.96 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131433343 | CMS |
| PFIZER INC. | $19.87 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131971471 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.